Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 19Unknown 13Active not recruiting 13Completed 10Terminated 5Not yet recruiting 3Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 40Breast Neoplasms 40Prostatic Neoplasms 24Colorectal Neoplasms 24Uterine Cervical Neoplasms 16Carcinoma, Non-Small-Cell Lung 14Anxiety Disorders 13Stomach Neoplasms 9Lymphoma, Follicular 9Lung Neoplasms 9Leukemia, Myeloid, Acute 9Carcinoma, Hepatocellular 8Brain Neoplasms 8Urinary Bladder Neoplasms 7Sarcoma 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Head and Neck Neoplasms 7Esophageal Squamous Cell Carcinoma 7Esophageal Neoplasms 7Ovarian Neoplasms 6Epilepsy 6Depression 6Colonic Neoplasms 6Uterine Cervical Dysplasia 5Small Cell Lung Carcinoma 5Pain 5Glioma 5Dementia 5Cholangiocarcinoma 5Recurrence 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Interventional × Metastatic Castration-resistant Prostate Cancer × Clear all
NCT05570994 2026-01-08

177Lu-HTK03170 in mCRPC With PSMA Positive Disease

British Columbia Cancer Agency

Phase 1/2 Enrolling by invitation
50 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡